[go: up one dir, main page]

ZA898554B - Liquid oral formulation - Google Patents

Liquid oral formulation

Info

Publication number
ZA898554B
ZA898554B ZA898554A ZA898554A ZA898554B ZA 898554 B ZA898554 B ZA 898554B ZA 898554 A ZA898554 A ZA 898554A ZA 898554 A ZA898554 A ZA 898554A ZA 898554 B ZA898554 B ZA 898554B
Authority
ZA
South Africa
Prior art keywords
oral formulation
liquid oral
formulation
diclofenac
preparation
Prior art date
Application number
ZA898554A
Inventor
Heidi Affolter
Affolter Heidi
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ZA898554B publication Critical patent/ZA898554B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to an aqueous oral pharmaceutical formulation of diclofenac, which can be used for treating pain and inflammatory processes, and also to the preparation of such a formulation.
ZA898554A 1988-11-10 1989-11-09 Liquid oral formulation ZA898554B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH416788 1988-11-10

Publications (1)

Publication Number Publication Date
ZA898554B true ZA898554B (en) 1990-08-29

Family

ID=4271057

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA898554A ZA898554B (en) 1988-11-10 1989-11-09 Liquid oral formulation

Country Status (16)

Country Link
EP (1) EP0373103B1 (en)
JP (1) JP2894744B2 (en)
KR (1) KR0152983B1 (en)
AT (1) ATE87476T1 (en)
AU (1) AU624190B2 (en)
CA (1) CA2002472C (en)
DE (1) DE58903964D1 (en)
DK (1) DK175752B1 (en)
ES (1) ES2054089T3 (en)
GR (1) GR3007995T3 (en)
IE (1) IE63482B1 (en)
IL (1) IL92190A (en)
NZ (1) NZ231320A (en)
PT (1) PT92228B (en)
SA (1) SA90100152B1 (en)
ZA (1) ZA898554B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011688A (en) * 1989-02-02 1991-04-30 Calam Henry D Liquid composition for the relief of premenstrual and menstrual discomforts
IT1256616B (en) * 1992-12-02 1995-12-12 Zambon Spa SYRUP CONTAINING N-ACETYL-CISTEIN
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
RU2003104808A (en) 2000-08-07 2004-08-20 Ранбакси Сигниче Ллк (Us) LIQUID COMPOSITION OF METFORMINE
ITMI20020986A1 (en) * 2002-05-10 2003-11-10 Acraf COMPOSITION BASED ON DICLOFENAC FOR THE TOPICAL TREATMENT OF AFFECTIONS OF THE OROPHARINGOUS CABLE
JP2004059488A (en) * 2002-07-29 2004-02-26 Asahi Food & Healthcare Ltd Lactobacillus intestinal disorder controlling composition and food
JP2006315966A (en) * 2005-04-11 2006-11-24 Sanei Gen Ffi Inc Liquid composition for pharyngolarynx containing black soybean extract
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
JP6200893B2 (en) 2011-10-31 2017-09-20 ノバルティス アーゲー Pazopanib formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
DD124950A5 (en) * 1975-07-04 1977-03-23
CH655507B (en) * 1983-01-12 1986-04-30

Also Published As

Publication number Publication date
IE893611L (en) 1990-05-10
DK561589D0 (en) 1989-11-09
KR0152983B1 (en) 1998-11-16
DK561589A (en) 1990-05-11
ATE87476T1 (en) 1993-04-15
PT92228A (en) 1990-05-31
KR910009253A (en) 1991-06-28
JPH02178224A (en) 1990-07-11
IL92190A (en) 1996-07-23
EP0373103B1 (en) 1993-03-31
DE58903964D1 (en) 1993-05-06
GR3007995T3 (en) 1993-08-31
AU624190B2 (en) 1992-06-04
EP0373103A1 (en) 1990-06-13
CA2002472C (en) 2000-05-30
NZ231320A (en) 1992-11-25
SA90100152B1 (en) 2001-04-14
PT92228B (en) 1995-07-06
DK175752B1 (en) 2005-02-07
IL92190A0 (en) 1990-07-26
AU4434389A (en) 1990-06-07
ES2054089T3 (en) 1994-08-01
IE63482B1 (en) 1995-05-03
CA2002472A1 (en) 1990-05-10
JP2894744B2 (en) 1999-05-24

Similar Documents

Publication Publication Date Title
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
NO881542D0 (en) CONDITIONING LIQUIDS OF DENTAL OR FUEL.
IE880061L (en) 1,2,4,5-tetrasubstituted benzene derivatives
ATE78696T1 (en) MEDICINAL PREPARATION FOR THE TREATMENT OF IMMUNE DEFICIENCY.
ZA898554B (en) Liquid oral formulation
FR2618331B1 (en) PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF UREMIA
DE69004532D1 (en) Medicinal preparations containing topical defibrotide.
PT76247A (en) Process for preparing antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes and of pharmaceutical compositions containing the same
ZA894945B (en) Strontium salt,process for the preparation thereof and pharmaceutical compositions containing it
PH24723A (en) Device and composition for treatment of the gums
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
GR3001277T3 (en) Chlorpheniramine therapy
NO165542C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-ARYL-2,4-DIALKYL-3H-1,2,4-TRIAZOL-3-THIONER.
EG18213A (en) Pharmaceutical formulation for the treatment of bacterial infections
ES8300475A1 (en) Modified allergens.
ZA877303B (en) Pharmaceutical composition for the treatment of high blood pressure
IL85093A0 (en) Pharmaceutical compositions containing retinoids for the treatment of psychotic illnesses
GB8709862D0 (en) Pharmaceutical compositions & treatment
GB8709860D0 (en) Pharmaceutical compositions & treatment
IT1224897B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIODONTAL AFFECTIONS
IT8919216A0 (en) DEVICE FOR THE SURGICAL TREATMENT OF ASTIGMATISM.
ITMI931174A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF THALASSEMIA
RO92740B1 (en) Medicinal composition for the treatment of otites